17-alpha-hydroxyprogesterone has been researched along with Pituitary Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becu-Villalobos, D; Cristina, C; Díaz-Torga, G; González-Iglesias, A; Suarez, C | 1 |
1 other study(ies) available for 17-alpha-hydroxyprogesterone and Pituitary Diseases
Article | Year |
---|---|
Upregulation of angiotensin II type 2 receptor expression in estrogen-induced pituitary hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Analysis of Variance; Animals; Calcium Signaling; Diethylstilbestrol; Down-Regulation; Estrogens, Non-Steroidal; Female; Hyperplasia; Pituitary Diseases; Pituitary Gland; Prolactin; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Up-Regulation | 2004 |